EP2416778
METHOD OF PREDICTING A PREDISPOSITION TO QT PROLONGATION BASED ON ABCC2 GENE SEQUENCE OR PRODUCT THEREOF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
5.4.2010EP published:
2.3.2016EP application number:
10712675.7
EPO information:
European Patent Register
Max expiry date:
4.4.2030
Title:
METHOD OF PREDICTING A PREDISPOSITION TO QT PROLONGATION BASED ON ABCC2 GENE SEQUENCE OR PRODUCT THEREOF
Timeline
Today
5.4.2010EP application
2.3.2016EP Publication
Owner
Name:
Vanda Pharmaceuticals Inc.Address:
2200 Pennsylvania Avenue Suite 300-E, 20037, Washington, DC, US
Inventor
Name:
LAVEDAN, ChristianAddress:
PotomacMD, US
Name:
VOLPI, SimonaAddress:
DerwoodMD, US
Name:
LICAMELE, LouisAddress:
GaithersburgMD, US
Priority
Number:
167139 PDate:
6.4.2009Country:
US
Classification
Categories:
A61K 31/519, C12Q 1/68